Octreotide Acetate
NDC 0641-6176, Octreotide Acetate, injection, solution, from Hikma Pharmaceuticals USA Inc..
- Product NDC
- 0641-6176
- Status
- Listed
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA076313
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0641-6176 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OCTREOTIDE ACETATE500 ug/mL
Pharmacologic classes
Somatostatin Analog [EPC]; Somatostatin Receptor Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0641-6176-10 | 00641617610 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0641-6176-10) / 1 mL in 1 VIAL, SINGLE-DOSE (0641-6176-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9502860d-0261-4d69-a4be-827a5376d356Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0641-6176
Use it
Look up 0641-6176 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0641-6176 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0641-6176. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.